Literature DB >> 25557798

Adenosine A1 receptor activation modulates N-methyl-d-aspartate (NMDA) preconditioning phenotype in the brain.

Leandra C Constantino1, Fabrício A Pamplona2, Filipe C Matheus3, Fabiana K Ludka4, Maricel Gomez-Soler5, Francisco Ciruela5, Carina R Boeck6, Rui D Prediger3, Carla I Tasca7.   

Abstract

N-methyl-d-aspartate (NMDA) preconditioning is induced by subtoxic doses of NMDA and it promotes a transient state of resistance against subsequent lethal insults. Interestingly, this mechanism of neuroprotection depends on adenosine A1 receptors (A1R), since blockade of A1R precludes this phenomenon. In this study we evaluated the consequences of NMDA preconditioning on the hippocampal A1R biology (i.e. expression, binding properties and functionality). Accordingly, we measured A1R expression in NMDA preconditioned mice (75mg/kg, i.p.; 24h) and showed that neither the total amount of receptor, nor the A1R levels in the synaptic fraction was altered. In addition, the A1R binding affinity to the antagonist [(3)H] DPCPX was slightly increased in total membrane extracts of hippocampus from preconditioned mice. Next, we evaluated the impact of NMDA preconditioning on A1R functioning by measuring the A1R-mediated regulation of glutamate uptake into hippocampal slices and on behavioral responses in the open field and hot plate tests. NMDA preconditioning increased glutamate uptake into hippocampal slices without altering the expression of glutamate transporter GLT-1. Interestingly, NMDA preconditioning also induced antinociception in the hot plate test and both effects were reversed by post-activation of A1R with the agonist CCPA (0.2mg/kg, i.p.). NMDA preconditioning or A1R modulation did not alter locomotor activity in the open field. Overall, the results described herein provide new evidence that post-activation of A1R modulates NMDA preconditioning-mediated responses, pointing to the importance of the cross-talk between glutamatergic and adenosinergic systems to neuroprotection.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Adenosine A(1) receptors; Glutamate; Hippocampus; NMDA preconditioning; Pain

Mesh:

Substances:

Year:  2014        PMID: 25557798     DOI: 10.1016/j.bbr.2014.12.056

Source DB:  PubMed          Journal:  Behav Brain Res        ISSN: 0166-4328            Impact factor:   3.332


  3 in total

1.  Neuroprotection induced by NMDA preconditioning as a strategy to understand brain tolerance mechanism.

Authors:  Leandra C Constantino; Samuel Vandresen-Filho; Carla I Tasca
Journal:  Neural Regen Res       Date:  2015-04       Impact factor: 5.135

2.  Role of Phosphatidylinositol-3 Kinase Pathway in NMDA Preconditioning: Different Mechanisms for Seizures and Hippocampal Neuronal Degeneration Induced by Quinolinic Acid.

Authors:  Leandra C Constantino; Luisa B Binder; Samuel Vandresen-Filho; Giordano G Viola; Fabiana K Ludka; Mark W Lopes; Rodrigo B Leal; Carla I Tasca
Journal:  Neurotox Res       Date:  2018-04-20       Impact factor: 3.911

3.  Adenosine A2A Receptor Antagonists Affects NMDA Glutamate Receptor Function. Potential to Address Neurodegeneration in Alzheimer's Disease.

Authors:  Rafael Franco; Rafael Rivas-Santisteban; Mireia Casanovas; Alejandro Lillo; Carlos A Saura; Gemma Navarro
Journal:  Cells       Date:  2020-04-26       Impact factor: 6.600

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.